Enzo Biochem Inc ENZB

$0.70 +0.01 (1.66%)

Valuation

Market cap
36,629,000
Revenue TTM
$31,910,000
Net income TTM
$-26,080,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-81.73%
Debt to equity
0.00

Trading

Volume
361,700
Avg volume
443,150
Day's range
$0.69 – $0.70
Shares out
52,409,000
Stochastic %K
97%
Beta
1.20
Analysts
—
Price target
—

Price

Company profile

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its...

Show more

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
631 755 5500
Website
https://www.enzo.com
Address
21 Executive Blvd, Farmingdale, United States

Latest news

No headlines yet.